Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2013-09-10

Clinical Trial Update: Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery

View source ↗

Summary

ClinicalTrials.gov update describes expanded access with cost recovery for the ELAD liver-support system in patients with liver failure; the program is no longe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELAD (extracorporeal liver assist device)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Liver Failure | Status: NO_LONGER_AVAILABLE